Adjuvant continuous metronomic adriamycin + cyclophosphamide followed by weekly nab-paclitaxel for high-risk early-stage breast cancer
Author:
Affiliation:
1. Palo Alto Medical Foundation; Sunnyvale CA USA
2. Fred Hutchinson Cancer Research Center; Seattle WA USA
3. Seattle Cancer Care Alliance; Seattle WA USA
4. University of Washington; Seattle WA USA
Funder
National Cancer Institute
Celgene
Publisher
Hindawi Limited
Subject
Oncology,Surgery,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/tbj.13013/fullpdf
Reference8 articles.
1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists’ Collaborative Group;Lancet,2005
2. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741;Citron;J Clin Oncol,2003
3. Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials;Bonilla;J Natl Cancer Inst,2010
4. Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer;Henderson;J Clin Oncol,2003
5. Weekly paclitaxel in the adjuvant treatment of breast cancer;Sparano;N Engl J Med,2008
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Metronomic chemotherapy for patients with metastatic breast cancer: Review of effectiveness and potential use during pandemics;Cancer Treatment Reviews;2020-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3